Vonoprazan
VOQUEZNA TRIPLE PAK, is a co-packaged product containing vonoprazan, a potassium-competitive acid blocker (PCAB), amoxicillin, a penicillin class antibacterial, and clarithromycin, a macrolide antimicrobial, indicated for the treatment of Helicobacter pylori (H.
United States
$623
per month
India
$5
per month
You save
−99.12%save $617/mo · 99.12% cheaper
37.6K US scripts/yr$23.2M potential annual savings$23.4M US spend/yr
Drag to rotate · 3D structureC17H16FN3O2S
SMILES: CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3
Compare the price
US price$623per month
India price$5per month
You save$61799.12% less
Based on 30 units per month. US $20.76 vs India $0.18 per unit.
Total over 1 periodSave $617$623 → $5
The bigger picture
Vonoprazan is filled about 37.6K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$23.4M
If sourced from India
$206.4K
Potential annual savings
$23.2M
−99%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.